Evidence map›Paper›PMID 40879413›Full record

ArticleJournal of Alzheimer's disease : JAD2025

Valuation of cognition bolt-ons for EQ-5D-5L in Japan: A comparative analysis of scaling factor and conventional models.

Ataru Igarashi, Aureliano Paolo Finch, Zhihao Yang, Yukinori Sakata, Mie Azuma-Kasai, Kiyoyuki Tomita, Mika Ishii, Manabu Ikeda

Abstract readComparative Study
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ataru IgarashiDepartment of Health Policy and Public Health, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Aureliano Paolo FinchEuroQol Research Foundation, Rotterdam, Netherlands.
Zhihao YangHealth Services Management Department, Guizhou Medical University, Guiyang, Guizhou Province, China.
Yukinori SakataEisai Co., Ltd., Bunkyo-ku, Tokyo, Japan.
Mie Azuma-KasaiEisai Co., Ltd., Bunkyo-ku, Tokyo, Japan.
Kiyoyuki TomitaEisai Co., Ltd., Bunkyo-ku, Tokyo, Japan.
Mika IshiiEisai Co., Ltd., Bunkyo-ku, Tokyo, Japan.
Manabu IkedaDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundA cognition bolt-on version for EQ-5D is needed to comprehensively assess health states of the general population.ObjectiveTo experimentally evaluate the valuation methods of the EQ-5D-5L bolt-ons using scaling factor and conventional models, we used the cognition bolt-on version of the Japanese EQ-5D-5L (EQ-5D-5L + C) and two previously developed cognition dimensions Remembering things and Thinking clearly.MethodsEligible participants, recruited from the general Japanese population, included adults living in three cities. Interviews were conducted from June to August 2023. Participants were randomized to Arms 1 (EQ-5D-5L + C), 2 (EQ-5D-5L + Remembering things), and 3 (EQ-5D-5L + Thinking clearly). Preferences were collected using a composite time trade-off (cTTO). The "1-cTTO" data were modeled using the scaling factor model, with EQ-5D-5L disutility weights estimated from the existing value sets. We also fitted the data into the conventional main-effects additive model. Both models used a tobit model and maximum likelihood estimation. Model performance was assessed using indices of fit.ResultsOverall, 864 individuals participated in the study. Addition of cognition dimensions to EQ-5D-5L expanded the scaling factor model coefficients in all arms. The observed mean and predicted "1-cTTO" values of the scaling factor model were not largely different in all three arms. The mean absolute errors of the scaling factor and conventional models were 0.0720 and 0.1305, 0.0748 and 0.0885, and 0.0985 and 0.0685 in Arms 1, 2, and 3, respectively.ConclusionsThe performance of the two models did not appear greatly different. Further experimental valuation studies using the scaling factor model and cognition items are warranted.

Indexed as

CognitionHealth StatusQuality of LifeAdultAgedFemaleHumansJapanMaleMiddle AgedSurveys and QuestionnairesAlzheimer's diseasecognitionhealth-related quality of lifehealth statuspublic healthvaluation

Identifiers

PMID40879413
PMCPMC12932683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.